Radnor Capital Management LLC bought a new stake in shares of Curtiss-Wright Co. (NYSE:CW – Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 7,141 shares of the aerospace company’s stock, valued at approximately $2,347,000.
Several other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in Curtiss-Wright by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 3,657,854 shares of the aerospace company’s stock worth $936,191,000 after purchasing an additional 18,939 shares during the last quarter. Boston Partners raised its holdings in Curtiss-Wright by 3.0% in the 1st quarter. Boston Partners now owns 1,393,662 shares of the aerospace company’s stock valued at $356,684,000 after buying an additional 40,657 shares during the period. Congress Asset Management Co. raised its holdings in Curtiss-Wright by 136.8% in the 3rd quarter. Congress Asset Management Co. now owns 459,074 shares of the aerospace company’s stock valued at $150,893,000 after buying an additional 265,205 shares during the period. International Assets Investment Management LLC raised its holdings in Curtiss-Wright by 32,425.8% in the 3rd quarter. International Assets Investment Management LLC now owns 404,946 shares of the aerospace company’s stock valued at $133,102,000 after buying an additional 403,701 shares during the period. Finally, Global Alpha Capital Management Ltd. raised its holdings in Curtiss-Wright by 41.7% in the 1st quarter. Global Alpha Capital Management Ltd. now owns 352,813 shares of the aerospace company’s stock valued at $90,299,000 after buying an additional 103,780 shares during the period. 82.71% of the stock is owned by hedge funds and other institutional investors.
Curtiss-Wright Stock Up 3.0 %
CW opened at $360.41 on Wednesday. The company has a quick ratio of 1.39, a current ratio of 1.98 and a debt-to-equity ratio of 0.39. The firm has a market cap of $13.68 billion, a P/E ratio of 34.10 and a beta of 1.17. Curtiss-Wright Co. has a 52 week low of $203.22 and a 52 week high of $371.04. The business’s fifty day simple moving average is $331.53 and its 200 day simple moving average is $297.08.
Curtiss-Wright Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, October 11th. Stockholders of record on Friday, September 27th were paid a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 0.23%. The ex-dividend date of this dividend was Friday, September 27th. Curtiss-Wright’s dividend payout ratio is currently 7.95%.
Insider Activity at Curtiss-Wright
In other Curtiss-Wright news, Director Glenda J. Minor sold 500 shares of Curtiss-Wright stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $302.80, for a total transaction of $151,400.00. Following the sale, the director now directly owns 1,382 shares in the company, valued at $418,469.60. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, VP John C. Watts sold 412 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $359.55, for a total transaction of $148,134.60. Following the completion of the transaction, the vice president now owns 4,183 shares in the company, valued at $1,503,997.65. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Glenda J. Minor sold 500 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $302.80, for a total value of $151,400.00. Following the transaction, the director now owns 1,382 shares of the company’s stock, valued at $418,469.60. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.55% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts have issued reports on CW shares. Morgan Stanley boosted their price target on shares of Curtiss-Wright from $334.00 to $395.00 and gave the stock an “overweight” rating in a research note on Tuesday. StockNews.com lowered shares of Curtiss-Wright from a “strong-buy” rating to a “buy” rating in a research note on Monday, September 23rd. Robert W. Baird upped their price target on Curtiss-Wright from $300.00 to $312.00 and gave the company an “outperform” rating in a report on Friday, August 9th. Stifel Nicolaus upped their price target on Curtiss-Wright from $318.00 to $361.00 and gave the company a “buy” rating in a report on Wednesday, October 16th. Finally, Alembic Global Advisors initiated coverage on Curtiss-Wright in a report on Tuesday, October 29th. They issued an “overweight” rating and a $412.00 price objective for the company. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $362.60.
Read Our Latest Analysis on CW
About Curtiss-Wright
Curtiss-Wright Corporation, together with its subsidiaries, provides engineered products, solutions, and services mainly to aerospace and defense, commercial power, process, and industrial markets worldwide. It operates through three segments: Aerospace & Industrial, Defense Electronics, and Naval & Power.
Read More
- Five stocks we like better than Curtiss-Wright
- What is the S&P 500 and How It is Distinct from Other Indexes
- 2 Alternative Internet Stocks Staging a Breakout in 2024
- How Investors Can Find the Best Cheap Dividend Stocks
- Discover the 3 Best-Performing Biotech IPO Stocks of 2024
- What is a buyback in stocks? A comprehensive guide for investors
- Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
Want to see what other hedge funds are holding CW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Curtiss-Wright Co. (NYSE:CW – Free Report).
Receive News & Ratings for Curtiss-Wright Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curtiss-Wright and related companies with MarketBeat.com's FREE daily email newsletter.